Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation

Xueyan Cao(First Affiliated Hospital of Zhengzhou University), Lin Miao(Tianjin University)
BMC Cancer
May 23, 2023
Cited by 21


Related Papers